Five-year followup of rheumatoid arthrit
β
Suzan M. M. Verstappen; Johannes W. G. Jacobs; Johannes W. J. Bijlsma; Anton H.
π
Article
π
2003
π
John Wiley and Sons
π
English
β 131 KB
π 2 views
## Abstract ## Objective To evaluate whether the clinical advantages observed after 1 year in a randomized controlled clinical trial, in which 2 treatment strategies were compared (the early diseaseβmodifying antirheumatic drug [DMARD] approach versus the pyramid approach), persist after 5 years.